DK1896019T3 - Formulering af en thienopyridin-blodplade-aggregationshæmmer - Google Patents
Formulering af en thienopyridin-blodplade-aggregationshæmmerInfo
- Publication number
- DK1896019T3 DK1896019T3 DK06772240T DK06772240T DK1896019T3 DK 1896019 T3 DK1896019 T3 DK 1896019T3 DK 06772240 T DK06772240 T DK 06772240T DK 06772240 T DK06772240 T DK 06772240T DK 1896019 T3 DK1896019 T3 DK 1896019T3
- Authority
- DK
- Denmark
- Prior art keywords
- formulation
- platelet aggregation
- aggregation inhibitor
- thienopyridine
- thienopyridine platelet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68918305P | 2005-06-10 | 2005-06-10 | |
| PCT/US2006/021860 WO2006135605A2 (en) | 2005-06-10 | 2006-06-06 | Formulation of a thienopyridine platelet aggregation inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1896019T3 true DK1896019T3 (da) | 2009-10-26 |
Family
ID=37198935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06772240T DK1896019T3 (da) | 2005-06-10 | 2006-06-06 | Formulering af en thienopyridin-blodplade-aggregationshæmmer |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US20080176893A1 (da) |
| EP (1) | EP1896019B1 (da) |
| JP (1) | JP2008543755A (da) |
| KR (2) | KR20100076050A (da) |
| CN (1) | CN101193633B (da) |
| AR (1) | AR054283A1 (da) |
| AT (1) | ATE441413T1 (da) |
| AU (1) | AU2006258102B2 (da) |
| BR (1) | BRPI0611350B8 (da) |
| CA (1) | CA2611668C (da) |
| CY (1) | CY1109502T1 (da) |
| DE (1) | DE602006008942D1 (da) |
| DK (1) | DK1896019T3 (da) |
| DO (1) | DOP2006000126A (da) |
| EA (1) | EA011693B1 (da) |
| EC (1) | ECSP077984A (da) |
| ES (1) | ES2330373T3 (da) |
| HK (1) | HK1116422A1 (da) |
| HR (1) | HRP20090516T1 (da) |
| IL (1) | IL187830A0 (da) |
| MA (1) | MA29688B1 (da) |
| MX (1) | MX2007015431A (da) |
| MY (1) | MY151038A (da) |
| NO (1) | NO20076317L (da) |
| NZ (1) | NZ564003A (da) |
| PE (1) | PE20070320A1 (da) |
| PL (1) | PL1896019T3 (da) |
| PT (1) | PT1896019E (da) |
| RS (1) | RS51194B (da) |
| SI (1) | SI1896019T1 (da) |
| TN (1) | TNSN07466A1 (da) |
| TW (1) | TWI318571B (da) |
| UA (1) | UA91051C2 (da) |
| WO (1) | WO2006135605A2 (da) |
| ZA (1) | ZA200710697B (da) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101594865A (zh) * | 2006-12-07 | 2009-12-02 | 第一三共株式会社 | 含有低取代的羟基丙基纤维素的药物组合物 |
| US20110201814A1 (en) * | 2006-12-07 | 2011-08-18 | Daiichi Sankyo Company Limited | Method for producing solid preparation |
| JP5289975B2 (ja) * | 2006-12-07 | 2013-09-11 | 第一三共株式会社 | マンニトール又は乳糖を含有する固形製剤 |
| EP2100606A4 (en) * | 2006-12-07 | 2009-12-30 | Daiichi Sankyo Co Ltd | COATED PREPARATION OF A FILM HAVING IMPROVED STABILITY |
| BRPI0719398A2 (pt) * | 2006-12-07 | 2015-03-31 | Daiichi Sankyo Company Ltd E Ube Ind Ltd | Composição farmacêutica. |
| JP2010512182A (ja) * | 2006-12-07 | 2010-04-22 | イーライ リリー アンド カンパニー | プラスグレルのための製品 |
| CA2679925C (en) * | 2007-03-02 | 2012-10-02 | Daiichi Sankyo Company, Limited | Method for producing high-purity prasugrel hydrochloride |
| EP2152078B8 (en) | 2007-04-27 | 2021-03-17 | CyDex Pharmaceuticals, Inc. | Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use |
| GB2450117A (en) * | 2007-06-13 | 2008-12-17 | Reckitt Benckiser Healthcare | A water- and oxygen-occlusive blister tablet pack |
| US20110003847A1 (en) | 2008-02-06 | 2011-01-06 | Helm Ag | Prasugrel Salts with Improved Properties |
| EP2107061A1 (en) * | 2008-04-02 | 2009-10-07 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of optically enriched clopidogrel |
| ATE482961T1 (de) * | 2008-04-25 | 2010-10-15 | Sandoz Ag | Hydrogensulfat von 2-acetoxy-5-(a- cyclopropylcarbonyl-2-fluorbenzyl)-4,5,6,7- tetrahydrothienoä3,2-cüpyridin und dessen zubereitung |
| EP2398468B1 (en) | 2009-02-17 | 2016-11-30 | KRKA, D.D., Novo Mesto | Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation |
| US8236782B2 (en) | 2009-05-13 | 2012-08-07 | Cydex Pharmaceuticals, Inc. | Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same |
| DE102009036646A1 (de) | 2009-08-07 | 2011-02-10 | Ratiopharm Gmbh | Prasugrel in nicht-kristalliner Form und pharmazeutische Zusammensetzung davon |
| JP2013032289A (ja) * | 2009-10-28 | 2013-02-14 | Daiichi Sankyo Co Ltd | ワックス安定製剤 |
| WO2011052499A1 (ja) * | 2009-10-28 | 2011-05-05 | 第一三共株式会社 | 貯蔵安定性が改善された医薬組成物 |
| WO2011092720A2 (en) * | 2010-02-01 | 2011-08-04 | Msn Laboratories Limited | Pharmaceutical composition of prasugrel and its pharmaceutically acceptable salts |
| TR201005900A1 (tr) | 2010-07-19 | 2012-02-21 | Sanovel İlaç San. Ve Ti̇c. A.Ş. | Geliştirilmiş stabiliteye sahip prasugrel granülleri. |
| TR201006802A1 (tr) * | 2010-08-17 | 2012-03-21 | Sanovel İlaç San. Ve Ti̇c. A.Ş. | Prasugrelin oral yolla dağılan formülasyonları. |
| TR201007926A1 (tr) | 2010-07-19 | 2012-02-21 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Prasugrel tablet formülasyonları. |
| EP2409685A3 (en) | 2010-07-19 | 2012-02-01 | Sanovel Ilac Sanayi ve Ticaret A.S. | Orally-disintegrating formulations of prasugrel |
| CZ2011872A3 (cs) | 2011-12-22 | 2013-07-03 | Zentiva, K.S. | Farmaceutická formulace prasugrelu hydrobromidu |
| US8603537B2 (en) | 2012-04-02 | 2013-12-10 | Egis Pharmaceuticals Plc | Prasugrel containing quickly released stable oral pharmaceutical compositions |
| WO2014060554A1 (en) | 2012-10-19 | 2014-04-24 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Prasugrel formulations |
| EP2722036A1 (en) | 2012-10-19 | 2014-04-23 | Sanovel Ilac Sanayi ve Ticaret A.S. | Solid oral formulations of prasugrel |
| CN102993210A (zh) * | 2012-12-19 | 2013-03-27 | 苏春华 | 一种吡啶并噻吩的新化合物 |
| EP2979693A1 (en) | 2014-08-01 | 2016-02-03 | Zaklady Farmaceutyczne Polpharma SA | Pharmaceutical composition comprising prasugrel or pharmaceutically acceptable salt thereof and process for its preparation |
| WO2016122421A1 (en) | 2015-01-29 | 2016-08-04 | Pharmactive Ilaç Sanayi Ve Ticaret A.Ş. | Stable pharmaceutical compositions containing prasugrel base |
| EP3158993A1 (en) | 2015-10-22 | 2017-04-26 | Zaklady Farmaceutyczne Polpharma SA | Process for preparing a tablet comprising prasugrel or pharmaceutically acceptable salt thereof |
| CN107304216A (zh) * | 2016-04-20 | 2017-10-31 | 陕西合成药业股份有限公司 | 噻吩吡啶类衍生物及其制备方法和用途 |
| HU231079B1 (hu) | 2016-06-23 | 2020-06-29 | Richter Gedeon Nyrt. | Eljárás nagytisztaságú Prasugrel előállítására bromopentil szennyezés eltávolításával |
| GR1009230B (el) | 2016-10-12 | 2018-02-22 | Φαρματεν Αβεε | Φαρμακευτικο σκευασμα που περιλαμβανει βεσυλικη πρασουγρελη |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI101150B (fi) * | 1991-09-09 | 1998-04-30 | Sankyo Co | Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi |
| JP4001199B2 (ja) * | 2000-07-06 | 2007-10-31 | 第一三共株式会社 | ヒドロピリジン誘導体酸付加塩 |
| KR20100105763A (ko) * | 2000-07-06 | 2010-09-29 | 다이이찌 산쿄 가부시키가이샤 | 히드로피리딘 유도체 산부가염 |
| EP1243524A3 (en) * | 2001-03-16 | 2004-04-07 | Pfizer Products Inc. | Pharmaceutical kit for oxygen-sensitive drugs |
| JP4394873B2 (ja) * | 2001-12-19 | 2010-01-06 | 武田薬品工業株式会社 | 酸素に不安定な化合物を含有する固形組成物およびその安定化方法 |
| SI21302A (sl) * | 2002-10-11 | 2004-04-30 | LEK farmacevtska dru�ba d.d. | Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino |
| US20050020554A1 (en) * | 2003-06-06 | 2005-01-27 | Ahmed Salah U. | Stability of hormone formulations |
| SK50462005A3 (sk) * | 2003-08-05 | 2005-09-08 | Zentiva, A. S. | Spôsoby stabilizácie atorvastatínu |
-
2006
- 2006-06-02 TW TW095119687A patent/TWI318571B/zh active
- 2006-06-06 US US11/913,889 patent/US20080176893A1/en not_active Abandoned
- 2006-06-06 UA UAA200712993A patent/UA91051C2/ru unknown
- 2006-06-06 CN CN2006800205289A patent/CN101193633B/zh active Active
- 2006-06-06 PT PT06772240T patent/PT1896019E/pt unknown
- 2006-06-06 EA EA200702670A patent/EA011693B1/ru not_active IP Right Cessation
- 2006-06-06 ES ES06772240T patent/ES2330373T3/es active Active
- 2006-06-06 CA CA2611668A patent/CA2611668C/en not_active Expired - Fee Related
- 2006-06-06 PL PL06772240T patent/PL1896019T3/pl unknown
- 2006-06-06 DO DO2006000126A patent/DOP2006000126A/es unknown
- 2006-06-06 AU AU2006258102A patent/AU2006258102B2/en not_active Ceased
- 2006-06-06 JP JP2008515813A patent/JP2008543755A/ja active Pending
- 2006-06-06 EP EP06772240A patent/EP1896019B1/en not_active Revoked
- 2006-06-06 AT AT06772240T patent/ATE441413T1/de active
- 2006-06-06 WO PCT/US2006/021860 patent/WO2006135605A2/en active Application Filing
- 2006-06-06 DE DE602006008942T patent/DE602006008942D1/de active Active
- 2006-06-06 DK DK06772240T patent/DK1896019T3/da active
- 2006-06-06 KR KR1020107011742A patent/KR20100076050A/ko not_active Application Discontinuation
- 2006-06-06 NZ NZ564003A patent/NZ564003A/en not_active IP Right Cessation
- 2006-06-06 MX MX2007015431A patent/MX2007015431A/es active IP Right Grant
- 2006-06-06 KR KR1020077028749A patent/KR20080008413A/ko not_active Application Discontinuation
- 2006-06-06 BR BRPI0611350A patent/BRPI0611350B8/pt active IP Right Grant
- 2006-06-06 RS RSP-2009/0425A patent/RS51194B/sr unknown
- 2006-06-06 SI SI200630490T patent/SI1896019T1/sl unknown
- 2006-06-08 PE PE2006000641A patent/PE20070320A1/es not_active Application Discontinuation
- 2006-06-09 MY MYPI20062708 patent/MY151038A/en unknown
- 2006-06-09 AR AR20060102430A patent/AR054283A1/es unknown
-
2007
- 2007-12-03 IL IL187830A patent/IL187830A0/en unknown
- 2007-12-07 TN TNP2007000466A patent/TNSN07466A1/en unknown
- 2007-12-07 NO NO20076317A patent/NO20076317L/no not_active Application Discontinuation
- 2007-12-07 ZA ZA200710697A patent/ZA200710697B/xx unknown
- 2007-12-07 EC EC2007007984A patent/ECSP077984A/es unknown
-
2008
- 2008-01-09 MA MA30568A patent/MA29688B1/fr unknown
- 2008-06-20 HK HK08106909.9A patent/HK1116422A1/xx not_active IP Right Cessation
-
2009
- 2009-09-25 HR HR20090516T patent/HRP20090516T1/xx unknown
- 2009-10-22 CY CY20091101101T patent/CY1109502T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1896019T3 (da) | Formulering af en thienopyridin-blodplade-aggregationshæmmer | |
| DK2024504T4 (da) | Fremstilling af isoprenoider | |
| DK1802579T3 (da) | Derivater af 3-arylaminopyridin | |
| DK2700786T3 (da) | Modifikation af overførselspassage | |
| CY2014012I1 (el) | Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης | |
| DK1981875T3 (da) | Substituerede indolylalkylaminoderivater som inhibitorer af histondeacetylase | |
| DK1940839T3 (da) | Pyridopyrimidione Inhibitors of P13Ka | |
| CR10693A (es) | Enantiomerically pure phosphoindoles as hiv inhibitors | |
| DK1778672T3 (da) | Krystallinsk form af en biphenylforbindelse | |
| DK2041138T3 (da) | Pyrroltriazinkinase-inhibitorer | |
| DK2024375T3 (da) | Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere | |
| DK1981892T3 (da) | Thienopyridinderivater som mek-inhibitorer | |
| DK1874766T3 (da) | Krystallinsk form af en quinolinon-carboxamid-forbindelse | |
| DK2091945T3 (da) | Nye inhibitorer af glutaminylcyclase | |
| DK2010496T3 (da) | 4-anilinoquinolin-3-carbonsyreamider som CSF-1R-kinaseinhibitorer | |
| DK1917227T3 (da) | Krystalformer af astaxanthin | |
| DK2031948T3 (da) | Bestemmelse af en komponents brugstid | |
| ATE503744T1 (de) | Nicht-nukleosidische reverse-transkriptase-hemmer | |
| ATE545642T1 (de) | Mmp-inhibitoren | |
| DK2083629T3 (da) | Krystallinsk modifikation af fipronil | |
| DK1955078T3 (da) | Blodpladeaggregeringsassays | |
| IS8294A (is) | Klópidógrel bísúlfat lyfjasamsetningar | |
| DK2118174T3 (da) | Anvendelse af tocopherol | |
| DK1877403T3 (da) | Mono-lysinsalte af azolforbindelser | |
| DK1705998T3 (da) | Anvendelse af en carboxypeptidase |